Regen Biopharma (RGBP) Stock Statistics & Valuation Metrics

Regen Biopharma has a market cap or net worth of $1.19M. The enterprise value is ―.

Regen Biopharma has 79,374,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Regen Biopharma’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 9.52%.

The current PE Ratio of Regen Biopharma is ―. Regen Biopharma’s PEG ratio is 0.00295.

In the last 12 months, Regen Biopharma had revenue of 236.56K and earned -668.00K in profits. Earnings per share was -0.16.

In the last 12 months, operating cash flow was -372.48K and capital expenditures -8.00, giving a free cash flow of -372.49K billion.

Regen Biopharma pays an annual dividend of ―, resulting in a dividend yield of ―

Regen Biopharma upcoming earnings date is ―, ―.

Regen Biopharma as a current ratio of 0.03, with Debt / Equity ratio of -17.82%

In the past 12 months, Regen Biopharma has paid 0.00 in taxes.

Regen Biopharma EV to EBITDA ratio is -2.96, with an EV/FCF ratio of -1.78.

Regen Biopharma has $1.76K in cash and marketable securities with $1.04M in debt, giving a net cash position of -$1.03M billion.

Gross margin is 100.00%, with operating margin of -176.28%, and net profit margin of -282.38%.

The average price target for Regen Biopharma is ―, which is 11.43% higher than the current price. The consensus rating is ―